Answers are grounded in this paper and cite their sources.
Demonstrates enhanced antitumor effects in immune checkpoint blockade through Th1 activation.
High Resolution Image Download MS PowerPoint Slide Cancer immunotherapy has achieved remarkable clinical success; however, its efficacy remains limited in many patients due to insufficient activation of antitumor immune responses. Green tea catechins are known to exert various biological activities, including immunomodulatory and anticancer effects; however, their low bioavailability highlights the importance of catechin-derived metabolites generated by the gut microbiota. In this study, we demonstrate that 5-(3′,5′-dihydroxyphenyl)-γ-valerolactone (EGC-M5), a major green tea catechin metabolite, promotes Th1 differentiation by activating the T-bet/IFN-γ axis in CD4 + T cells and subsequently activates IL-12 expression in splenic cells. Activation of this pathway effectively enhances CD8 + T cell infiltration into the tumor microenvironment, thereby potentiating the antitumor efficacy of PD-1 blockade. These findings indicate that EGC-M5 activates Th1-mediated immune responses and support its potential use as a therapeutic adjuvant for cancer therapy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: